Viewing Study NCT03908333


Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2026-02-25 @ 6:31 PM
Study NCT ID: NCT03908333
Status: WITHDRAWN
Last Update Posted: 2019-05-30
First Post: 2019-04-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer
Sponsor:
Organization:

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:

Phases

Phase Brief Phase Text View
None PHASE1 View
None PHASE2 View
Observational Models:
Time Perspective List:
Who Masked List: